Trends in mortality from idiopathic pulmonary fibrosis in the European Union: an observational study of the WHO mortality database from 2001–2013 Source: Eur Respir J, 51 (1) 1701603; 10.1183/13993003.01603-2017 Year: 2018
A national registry for childhood interstitial and diffuse lung diseases in the United States. Source: International Congress 2018 – Progress in rare interstitial lung diseases Year: 2018
Prevalence and mortality in chronic obstructive pulmonary disease-related hospitalizations – United States, 1979 – 2001 Source: Annual Congress 2004 - Burden of obstructive lung diseases: costs, mortality and life impairment Year: 2004
A systematic review of the occupational burden of chronic obstructive pulmonary disease in the Commonwealth of Independent States Source: Virtual Congress 2021 – Chronic airway, interstitial, pleural and neoplastic diseases Year: 2021
Incidence and prevalence of IPF in an insurance claims database: Assessing accuracy using medical records Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014
Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017
Incidence of idiopathic pulmonary fibrosis in Italy. Analysis of hospital admission and mortality databases of a large Italian region Source: Annual Congress 2013 –Diffuse pulmonary fibrosis Year: 2013
Health care visits among women with chronic obstructive pulmonary disease in the United States Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden Year: 2016
Mortality benefit with antifibrotics in idiopathic pulmonary fibrosis: real world evidence or bias? Source: Eur Respir J, 57 (3) 2004562; 10.1183/13993003.04562-2020 Year: 2021
Mortality risk and pulmonary function in adults with cystic fibrosis at time of wait listing for lung transplantation in the United States Source: International Congress 2015 – Outcomes of lung transplantation Year: 2015
Mortality due to IPF and mesothelioma in Europe – A link with historic asbestos use? Source: International Congress 2016 – Population-based insights into occupational and environmental lung disease Year: 2016
Occupational risk factors and idiopathic pulmonary fibrosis. A case-control study Source: Annual Congress 2007 - The air we breathe at home and at work Year: 2007
Impact of chronic obstructive pulmonary disease on specific-cause of mortality: a national cohort study Source: International Congress 2019 – Lung function evaluation and prognosis of airway diseases Year: 2019
Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review Source: Eur Respir J 2015; 46: 795-806 Year: 2015
The increasing mortality of idiopathic pulmonary fibrosis: fact or fallacy? Source: Eur Respir J, 51 (1) 1702420; 10.1183/13993003.02420-2017 Year: 2018
Historical eye on idiopathic pulmonary fibrosis: redefining the mortality scenario. Source: Virtual Congress 2020 – New clinical insights into idiopathic pulmonary fibrosis Year: 2020
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada Source: Eur Respir J 2016; 48: 187-195 Year: 2016
Median survival in unselected patients with idiopathic pulmonary fibrosis in the United Kingdom Source: Annual Congress 2013 –Diffuse parenchymal lung disease III Year: 2013
Course of disease and cause of death in patients with idiopathic pulmonary fibrosis in Eastern Finland Source: International Congress 2015 – IPF: clinical aspects Year: 2015
Epidemiology and mortality of non-idiopathic pulmonary fibrosis (IPF) progressive fibrosing interstitial lung disease (PF-ILD) using the French national health insurance system (SNDS) database in France: the PROGRESS study Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more Year: 2020